Is endometriosis more common and more severe than it was 30 years ago?
Current estimates of endometriosis prevalence and incidence are highly variable, leading to uncertainty regarding true endometriosis frequency or validity of quantified changes over time. We present a comprehensive review of the prevalence, incidence and stage of endometriosis worldwide as reported over the past 30 years. We conducted a systematic search of observational studies utilizing PubMed, Web of Science, EMBASE, and CINAHL to identify research papers published in the English language between January 1989 and June 2019. Search terminologies were limited to titles containing: endometriosis and prevalence or incidence, or epidemiology, or frequency, or occurrence, or statistics. Two independent reviewers screened abstracts for study eligibility. Data from included studies were abstracted. Overall, 69 studies describing the prevalence and/or incidence of endometriosis met the inclusion criteria. Among these, 26 studies were from general population samples, 16 of which were from regional/national hospital or insurance claims systems. The other 43 studies were conducted in single clinic or hospital settings. Prevalence estimates for endometriosis varied widely from 0.2% to 71.4% depending on the population sampled. The prevalence reported from general population studies ranged from 0.7% to 8.6%, while among single clinic or hospital-based studies ranged from 0.2% to 71.4%. When defined by indications for diagnosis, endometriosis prevalence ranged from 15.4% to 71.4% among women with chronic pelvic pain, 9.0% to 68.0% among women presenting with infertility, and 3.7% to 43.3% among women undergoing tubal sterilization. A meta-regression was conducted with year as the predictor for prevalence. No trend across time was observed among 'general population in country/region' studies (β=0.04, p=0.12) nor among 'single hospital or clinic' (β=-0.02, p=0.34) studies, however a decrease over time was observed among 'general population studies abstracted from health system/insurance systems' (β=-0.10, p=0.005). As with all human studies, population sampling and study design matter. Heterogeneity of inclusion and diagnostic criteria and selection bias overwhelmingly account for variability in endometriosis prevalence estimated across the literature. Thus, it is difficult to conclude if the lack of observed change in frequency and distributions of endometriosis over the past 30 years is valid.